(2000). Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Vol. 1, No. 4, pp. 45-54.
No takes yet. Share an insight, caveat, or question.
Kaitlin Brooks (2000) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: